We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
An integrated approach to assess exposure and early health effects in human populations exposed to micro- and nanoplastics
AI summary Read the abstract
This paper outlines a proposed framework for systematically assessing human exposure to micro- and nanoplastics and their early health effects, noting that current estimates are hindered by a lack of standardized detection methods. Researchers emphasize that occupational settings where plastics are processed, as well as vulnerable populations like children and pregnant women, should be prioritized for study. The study calls for validated biomarkers and standardized protocols to better understand the real-world health consequences of human microplastic exposure.
Although cumulative evidence from in vitro and in vivo studies indicates that micro- and nanoplastics (MNPs) can induce toxic effects, and MNPs have been detected in several human fluids and tissues, the consequences of MNP exposure to human health still remain unknown. Human biomonitoring (HBM) studies allow assessing human exposure to MPs and associated adverse health effects, contributing to the risk assessment of these environmental pollutants. To date, reliable human exposure estimates are hindered by the lack of standardized processing and analytical methods to detect MNPs in human tissues, and limited evidence on the MNP-related adverse health effects exists. Occupational environments, where plastics are processed, may represent prioritized settings for such evaluations, as workers typically face higher exposure levels than the general population. Population sub-groups with potentially higher susceptibility, such as children and pregnant women, should also be considered. To develop effective preventive strategies, it is essential to identify and validate sensitive and specific biomarkers of exposure and early biological changes, which could result in adverse health effects. Standardized protocols integrating environmental exposure assessment with HBM, and sensitive methods for evaluating internal dose resulting from cumulative exposure to MNP particles and associated chemicals are needed. Based on the experience gathered by a multidisciplinary panel of experts belonging to the European Research Cluster to Understand the Health Impacts of MNPs (CUSP), this consensus paper describes the key elements that should be part of an integrated HBM approach for MNP exposure, emphasizing existing challenges and proposing solutions for future studies.
More Papers Like This
Emerging Analytical Methodologies for Micro- and Nano-Plastics Detection in Human Samples: Analytical Challenges and Health Risk Perspectives
AI summary Read the abstract
Scientists have found tiny plastic particles (microplastics and even smaller nanoplastics) throughout human organs and body fluids, but this review of existing research shows we still lack reliable, standardized tools to accurately measure them—different labs get different results depending on how they prepare and test samples. While lab studies suggest very small plastic particles can cause cell stress and inflammation, there isn't yet solid evidence directly linking plastic exposure to specific diseases in people—so the biggest takeaway is that we urgently need better testing methods before we can truly understand the health risks these particles pose.
Towards a risk assessment framework for micro- and nanoplastic particles for human health
AI summary Read the abstract
This review proposes a framework for assessing the health risks of micro- and nanoplastics to humans, noting that current methods are inadequate because these particles come in countless types, sizes, and chemical compositions. The authors recommend focusing first on inhalation risks and suggest using existing approaches for evaluating low-toxicity particles and fibers as a starting point for plastic particle safety standards.
Impacts of micro- and nanoplastics on early-life health: a roadmap towards risk assessment
AI summary Read the abstract
Researchers proposed a detailed risk assessment roadmap specifically for how micro- and nanoplastic exposure during pregnancy and early childhood could harm fetal and infant development, noting that these tiny particles have already been detected in human placentas. The framework identifies critical gaps in dosing data, detection methods, and placental transfer research needed before reliable safety conclusions can be drawn.
Microplastics and nanoplastics: Exposure and toxicological effects require important analysis considerations
AI summary Read the abstract
This review highlights that while microplastics and nanoplastics have been found in human tissues and linked to several diseases, the actual toxic effects are still unclear because researchers use very different methods to study them. The authors call for standardized testing approaches so that results can be compared reliably, which is critical for determining what levels of exposure actually pose a risk to human health.
Understanding Human Health Impacts Following Microplastic Exposure Necessitates Standardized Protocols
AI summary Read the abstract
This overview examines the methods currently used to study how microplastics affect human health, highlighting significant inconsistencies in experimental approaches. Researchers identified challenges including the lack of standardized reference materials, variability in exposure conditions, and limited understanding of how microplastic doses translate to real-world exposure. The study proposes solutions to standardize protocols so that future research builds on a more reliable foundation.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.